Dashboard
Curated content
All companies
Job board
Funding rounds
Exits
Matching tool
Investment heatmap
Companies
Sharp Peptide Biotechnology (Dalian) Group
Save
Sharp Peptide Biotechnology (Dalian) Group
Launch date
Jul 2021
Market cap
-
Enterprise valuation
€15—22m
(Dealroom.co estimates May 2023.)
Dalian Liaoning (HQ)
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Sharp Peptide Biotechnology (Dalian) Group funding
Sharp Peptide Biotechnology (Dalian) Group investors
Edit
Date
Investors
Amount
Round
May 2023
*
Sculptor
$4.0m
Series A
Total Funding
€3.6m
Recent News about Sharp Peptide Biotechnology (Dalian) Group
Edit
